In the BioHarmony Drug Report Database
Methsuximide
Celontin (methsuximide) is a small molecule pharmaceutical. Methsuximide was first approved as Celontin on 1982-01-01. It is used to treat absence epilepsy and epilepsy in the USA.
Trade Name
|
Celontin |
|---|---|
Common Name
|
methsuximide |
ChEMBL ID
|
CHEMBL697 |
Indication
|
absence epilepsy, epilepsy |
Drug Class
|
Image (chem structure or protein)